[1]
I. L. Lewandowska, M. Zielińska-Pisklak, Łukasz Szeleszczuk, D. Maciej Pisklak, and M. Sobczak, “PULMONARY HYPERTENSION — PATHOPHYSIOLOGY AND DRUGS USED IN THERAPY”, Prosp. Pharm. Sc., vol. 18, no. 2, pp. 10–18, Aug. 2020.